title: Expression of receptors of advanced glycation end product (RAGE) and types I, III and IV collagen in the vastus lateralis muscle of men in early stages of knee osteoarthritis.
abstract: Alterations in the contractile and non-contractile proteins of the skeletal muscle may reduce muscle function in knee osteoarthritis (OA), and the formation and accumulation of advanced glycation end products, particularly in collagen, can influence the quality of these muscle proteins. The objective of this study was to evaluate the reactivity of types I, III and IV collagen and the expression and localization of receptor for advanced glycation end products (RAGE) in the vastus lateralis (VL) muscle in early stages of knee OA. The hypothesis was that these patients present a higher expression of RAGE and increased immunoreactivity in the collagen. Thirty-five men were divided into two groups: the control group (CG; n = 17) and the osteoarthritis group (OAG; n = 18). All participants were submitted to a biopsy of the VL. The muscle samples were analyzed by immunohistochemistry for collagen and for RAGE and laminin. The expression of RAGE was counted (intracellular, extracellular and total). Student's t-test for independent samples and Mann-Whitney U test were used for the RAGE's intergroup analysis (α ≤ 0.05). A semiquantitative analysis was performed to assess the collagen reactivity. No significant differences were observed in the intracellular, extracellular or total localization of RAGE (p > 0.05). Higher immunoreactivity was observed in the OAG for all types of collagen, with more reactivity for collagen III and IV. We concluded that in the initial stages of knee OA, no differences were observed for RAGE levels between the groups. However, the OAG's higher collagen expression may represent adaptations for reducing muscle stiffness and avoiding injury.
authors.affiliation: Department of Physical Therapy .
authors.forename: Paula Regina M S
authors.initials: PR
authors.lastname: Serrão
authors.forename: Fernando A
authors.initials: FA
authors.lastname: Vasilceac
authors.forename: Karina
authors.initials: K
authors.lastname: Gramani-Say
authors.forename: Giovanna C
authors.initials: GC
authors.lastname: Lessi
authors.forename: Rodrigo B M
authors.initials: RB
authors.lastname: Reiff
authors.forename: Ana Cláudia
authors.initials: AC
authors.lastname: Mattiello-Sverzut
authors.forename: Stela M
authors.initials: SM
authors.lastname: Mattiello
mesh_terms: D001696:Biomechanical Phenomena; D024022:Fibrillar Collagens / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D020370:Osteoarthritis, Knee / Q000378:metabolism / Q000503:physiopathology*; D052097:Quadriceps Muscle / Q000378:metabolism*; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000378:metabolism*; D018709:Statistics, Nonparametric
chemical_list: D024022:Fibrillar Collagens; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic
keywords: Collagen; RAGE; knee osteoarthritis; laminin; vastus lateralis muscle